Related articles

Pancreatic cancer

Tumor with historically poor prognosis; daraxonrasib produced unprecedented survival gains in metastatic disease.

• Oncologists in Chicago and Madrid Erupt in Standing Ovations for Breakthroughs Against Pancreatic and Lung Cancer